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TO THE EDITOR
Hair follicle size is correlated with the
size of the dermal papilla (DP) (Ibrahim
and Wright, 1982; Elliott et al., 1999).
DP size is dynamically regulated during
the follicle growth cycle. Cells emigrate
from the DP during catagen and then
repopulate it in anagen (Tobin et al.,
2003; Chi et al., 2010). The follicle
miniaturization seen in androgenetic
alopecia is thought to be driven by
dysfunctional DP cell (DPC) movement,
whereas hypertrichosis is caused by
excessive DPC migration or prolifera-
tion, producing an abnormally large DP
(Jahoda, 1998).
The mechanisms that determine DP
size are poorly understood. An in vitro
model for DP morphogenesis would
facilitate their investigation. DPCs are
well known to aggregate in culture,
which is likely to be an expression of
their morphogenetic behavior. How-
ever, DPC aggregation is variable and
is typically lost after a period of culture
ex vivo (Horne et al., 1986; Song et al.,
2005). In contrast, we have found that
ovine wool follicle DPCs exhibit parti-
cularly robust and stable aggregation.
We have optimized culture conditions
for these cells to establish a model for
DP morphogenesis and a quantitative
assay for aggregate size.
Cultures of ovine DPCs were initiated
by microdissecting papillae and ex-
planting them in culture medium
(Supplementary Methods online). The
cells showed a fibroblastic morphology
(Figure 1a), and formed whorl patterns
on reaching confluence (Figure 1b).
Localized variations in density then began
to appear (Figure 1c and d). The high-
density patches continued to condense,
eventually forming three-dimensional
spheroids projecting up from the culture
substrate (Figure 1e–g). The spheroids
could be stained with Van Gieson’s
solution (Figure 1h and i), allowing
measurement of their size by image
analysis.
Alkaline phosphatase (AP) is expres-
sed in the DP in vivo (Rendl et al.,
2005). AP staining was observed in most
ovine DPCs composing aggregates
(Figure 1j–l). Versican, a proteoglycan
also associated with DP formation
(Kishimoto et al., 1999), was expressed
only in aggregating cells (Figure 1m
and p).
Of the 19 cell strains from 12 sheep,
11 consistently aggregated as described
above, for at least 5 passages. Among
three strains (from two sheep), there was
no loss of aggregative behavior before
replicative senescence at 80.3–93.0
population doublings (22–27 passages,
Supplementary Figure S1 online).
Another 5 of the 19 strains aggregated
in early passages but were not further
tested. Three strains did not form dis-
crete aggregates suitable for size
determination.
We established a standardized assay
for quantifying the effect of bioactive
compounds on aggregate size (Supple-
mentary Methods online, Supplemen-
tary Figure S2 online). The addition
of 10–30 mM lithium chloride (LiCl)
induced a dose-dependent reduction in
size (Figure 2a and b). Aggregation was
abolished at a concentration of 40 mM.
Dorsomorphin (a BMPR-1 and VEGFR-2
inhibitor) and SU5402 (a FGFR-1 and
VEGFR-2 inhibitor) also reduced the
aggregate size (Figure 2c and d). LiCl
has pleiotropic effects on intracellular
signaling, including action as a Wnt
mimetic and an inhibitor of inositol
phospholipid signaling (Chiu and
Chuang, 2010). In light of the broad
specificity of these compounds, the
molecular mechanisms underlying
aggregate miniaturization remain to be
determined. The effects of additional
compounds are shown in Supplemen-
tary Figure S3 online. The hair-loss drug,
minoxidil, reversed the aggregate min-
iaturization induced by LiCl (Figure 2e).
The effects of LiCl on aggregation
persisted after it was removed from the
cells (Supplementary Figure S4a online).
We investigated the effect of LiCl
pretreatment on the in vivo induction
of hair follicles by ovine DPCs
(Supplementary Figure S4b–f online).
LiCl at a concentration of 40 mM
blocked follicle induction in vivo, as
well as aggregation in vitro (Supplemen-
tary Table S1 online).
To our knowledge, a DPC culture
system that permits quantitative mea-
surement of aggregate size has not pre-
viously been reported. Although human
and rodent DPCs exhibit aggregative
behavior (Messenger, 1984; Horne
et al., 1986; Song et al., 2005), the
aggregates are less well formed, with
less well-defined boundaries that pre-
clude size measurement. Aggregation
typically diminishes and then dis-
appears as the cells continue to be
propagated ex vivo. We found that
robust aggregation of ovine DPCs
continued after extensive growth in
culture, allowing numerous assays to
be performed with the same cell
population.
DPC aggregates expressed AP and
versican, whereas monolayers did not.
AP and versican are expressed in DP
in vivo and are markers of follicle-
inducing activity (Kishimoto et al.,
1999; Rendl et al., 2005). The
localized expression of these markers
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Figure 1. Formation and molecular characterization of dermal papilla cell (DPC) aggregates. (a) Subconfluent cells were typically stellate or spindle shaped.
(b) After becoming confluent, cells formed whorl patterns. (c) The homogenous cell layer then separated to expose the substrate. (d) Multiple layers of cells further
contracted to form dense ridges or clusters. (e) Two discrete, spheroid aggregates. (f) Scanning electron micrograph (SEM) of ridge-like and papilla-like
aggregates. (g) Side-view SEM of a papilla-like aggregate. (h) Aggregates of DPCs grown in a 22-mm diameter tissue culture well and stained with Van Gieson’s
stain for image analysis. (i) Higher-power view of the area inside the green box in h. (j-l) Alkaline phosphatase (AP) staining viewed with phase contrast. Positive AP
staining was observed in whole aggregates, in portions of aggregates (j), in patches of dense cells (k), or was negative in some aggregates (l). (m) Versican
immunofluorescence in aggregated cells and early-forming aggregate (arrow), but not surrounding uninvolved cells. (n) Vimentin immunofluorescence in both
aggregated and non-aggregated cells, providing a control for the effect of cell density on signal intensity. (o) IgG1-negative control at the same exposure settings as
in m. (p–r) 40,6-Diamidino-2-phenylindole (DAPI) counterstained cells (nuclear stain) corresponding to m–o. Bars¼200mm (a–e, i–r), 100mm (f, g), or 2 mm (h).
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suggests that ovine DPCs reestablish a
phenotype closer to papillae in vivo as
they form aggregates. In future studies, it
would be useful to more fully charac-
terize the phenotype of aggregates by
evaluating the expression of additional
in vivo papilla markers (Higgins et al.,
2010), as well as markers of cell
proliferation and death.
Does the behavior of ovine DPCs
reflect a morphogenetic process that is
common to humans and other species?
Sheep have been selected for enhanced
wool growth throughout their domesti-
cation, and maintain anagen even when
wool production is nutritionally limited
(Reis and Sahlu, 1994). The hair-
inducing activity of rat vibrissae DPCs
is more stable in culture media with
increased concentrations of amino acids
and vitamins (Park et al., 2006),
suggesting that nutritional stress may
contribute to the loss of morphogenetic
activity in culture. We speculate that
ovine DPCs have enhanced resistance
to nutritional stress, allowing them to
retain a stable phenotype in a culture
environment that imperfectly replicates
their physiological niche.
However, it is unlikely that the funda-
mental mechanisms of DP morphogen-
esis are different in sheep compared
with other species. The anatomy, onto-
geny, and molecular physiology of
ovine wool follicles are similar to those
of follicles from other species (Rogers,
2006). Wool follicles are in some
respects a better model for human
scalp follicles than rodents’ follicles.
Both sheep and human skin lack the
complex pelage structure arising from
distinct follicle types. The growth cycles
of both wool and human scalp follicles
incorporate prolonged anagen and
relatively short telogen.
In summary, the aggregative behavior
of ovine DPCs appears to represent a
morphogenetic process that is common
to other species, but more stable
ex vivo. These cells will provide a useful
experimental tool for investigating the
signaling pathways, bioactive com-
pounds, and genes that regulate the size
of dermal papillae.
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Figure 2. Effect of bioactive compounds on DPC aggregation. Cells were seeded onto collagen-coated substrates and maintained in medium containing different
concentrations of each compound. Aggregate diameters were measured by image analysis. (a) Seven strains of DPCs were treated with LiCl. Data for each strain
are plotted with a different symbol. Some strains (open symbols) produced comparatively few, but large, aggregates. The broken line shows the mean of all repeats,
weighted by aggregate numbers. (b) Giemsa-stained aggregates formed in 10 and 20 mM LiCl. Bars¼ 1 mm. DPCs were also treated with (c) dorsomorphin,
(d) SU5402, or (e) minoxidil sulphate (the active metabolite of minoxidil), in the absence or presence of LiCl at 10 mM or 20 mM, plotted using different symbols.
An additive effect was seen when dorsomorphin and SU5402 were combined with LiCl, whereas minoxidil diminished the effect of LiCl. Data represent means of
four repeats, each using a different cell strain, except that only three strains were used for minoxidil sulphate (e). Error bars are SEM.
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TO THE EDITOR
T lymphocytes express a variety of
voltage-gated potassium channels (Kv)
that greatly affect T-cell function (Szabo`
et al., 2010; Feske et al., 2012). Namely,
Kv1.3 channels regulate autoreactive
effector memory T cells, which are
implicated in the pathogenesis of
several autoimmune diseases (Beeton
et al., 2001, 2006, 2008; s4). Kv1.3
channel blockers may therefore offer
a therapeutic option in several auto-
immune disorders (Wulff et al., 2003a).
This may include alopecia areata (AA), a
T-cell–dependent autoimmune disease,
in which hair follicles (HFs) are attacked
by a dense lymphocytic infiltrate of
activated CD4þ and CD8þ T cells
(s9, s17, s15, Gilhar et al., 2012).
After grafting to SCID mice, lesional
(alopecic) scalp skin from AA patients
regrows hair when the infiltrating scalp
lymphocytes are lost (s14, s15, Gilhar
et al., 2012), whereas AA-like hair loss
can be induced in this humanized
mouse model of AA by injecting
lesional T cells (s13, s15). Previous
work by us and others had suggested
that NK cells and NKG2D ligands have a
major role in AA (Ito et al., 2008;
Petukhova et al., 2010). Moreover,
recently we demonstrated that it is
possible to induce AA lesions in healthy
human scalp transplants on SCID mice
only by injection of peripheral blood
mononuclear cells (PBMCs) greatly
enriched for NKG2Dþ and CD56þ
cells, which includes NK, NKT, and
some CD8þ T cells (Gilhar et al., 2013).
Therefore, we hypothesized that inhi-
biting T-cell function in AA by well-
tolerated Kv1.3 blockers may constitute
a therapeutic approach to AA manage-
ment, and asked the following ques-
tions: (1) Are Kv1.3þ T cells increased
in lesional AA skin? (2) Does Kv1.3-
selective potassium channel blockade
alter the development of AA lesions
in a humanized mouse model of AA
(Gilhar et al., 2013)?
First, we obtained biopsies from
lesional skin of 10 patients with AA
after informed consent and institutional
review board approval. Second, normal
scalp skin from healthy volunteers was
grafted onto beige SCID mice. ThreeAccepted article preview online 20 March 2013; published online 2 May 2013
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